ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

C1AH34 Cardinal Health, Inc.

515.32
0.00 (0.00%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Cardinal Health Financial Summary

The current C1AH34 market cap is 131.2B. The company's latest EPS is USD 1.0251 and P/E is 96.10.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 50.56B53.5B54.8B57.46B54.91B
Operating Income 592M504M523M483M503M
Net Income 345M-64M5M353M258M
Year End June 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 145.53B152.92B162.47B181.36B205.31B
Operating Income 1.57B-3.51B549M1.46B1.98B
Net Income 1.36B-3.7B611M-933M261M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 43.38B43.42B43.71B46.57B45.88B
Total Liabilities 45.6B46.27B47.2B50.02B49.14B
Total Equity -2.22B-2.85B-3.49B-3.45B-3.26B
Year End June 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 40.96B40.77B44.45B43.88B43.42B
Total Liabilities 34.63B38.97B42.66B44.58B46.27B
Total Equity 6.33B1.79B1.79B-706M-2.85B
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 1.98B2.84B545M1.73B1.69B
Investing -248M-454M-63M-168M-2.02B
Financing -2.46B-3.05B-666M-1.02B12M
Year End June 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 2.72B1.96B2.43B3.12B2.84B
Investing 338M493M-378M567M-454M
Financing -2.29B-2.2B-1.32B-2.46B-3.05B
Market Cap 131.2B
Price to Earnings Ratio 96.10
Price to Sales Ratio 0.12
Price to Cash Ratio 6.2
Price to Book Ratio -8.8
Dividend Yield 1.36%

Share Statistics

Shares Outstanding 254.6M
Average Volume (1 week) 8
Average Volume (1 Month) 3
52 Week Change 14.39%
52 Week High 553.84
52 Week Low 435.61
Spread (Intraday) 3.12 (0.59%)

Company Info

Company Name Cardinal Health, Inc.
Address 4400 easton commons way
columbus, georgia 43219
Website https://www.cardinalhealth.com
Industry drugs and proprietary-whsl (5122)